Introduction
PresentationVirtual mode
The appearance of COVID - 19 and its rapid expansion worldwide has conditioned a radical change at all levels, but this change has been much more drastic and dramatic in all aspects related to health care, establishing a change in paradigms. that over the last centuries we had learned and used for the interrelation with the patient, the formation of future healthcare professionals and the resources derived from translational research.
This radical change has established an impact at the social level, making global care for patients affected by this disease the main priority in most countries, regardless of their location, social, political or economic structure. But in addition, and with the passage of time, we are being able to verify the enormous effect that social and interaction norms establish on the development of this disease, which has conditioned that many prestigious authors begin to speak of a syndemic instead of a pandemic.
At the present time, there is a clear demand on the part of our society so that among all of us, we are able firstly to put a stop to this disease and secondly to establish the bases for its definitive control and this demand is increasingly evident as a consequence of the enormous impact that it is producing at all levels, even changing the rules of daily coexistence that we had known and used for centuries.
From a purely health point of view, in December 2019 the transmission of a new pneumonia-producing coronavirus was detected in Wuhan (China), which was identified by gene sequencing analysis through samples from the lower respiratory tract. It was decided to name the infective agent type 2 coronavirus (SARS-CoV-2) and the disease produced by it as COVID-19.
Given the existing ignorance in the face of the rapid expansion of the agent and the absence of scientific evidence of sufficient robustness to have a standardized treatment, multiple therapeutic resources have been used to control one of the main problems expressed within this disease, such as severe acute respiratory failure, not currently having an action plan with sufficient scientific support to allow homogeneity from the therapeutic point of view.
For all the above, it is urgent to have regulated and standardized training actions that are capable of laying the foundations of clinical, diagnostic, therapeutic and prognostic action in this very particular type of patients affected by an emerging disease with an enormous capacity to generate situations consistent with multi-organ dysfunction and a high mortality and morbidity rate.
Finally, and when treating a disease that as such did not exist a year ago, the necessary training to cope is not regulated. It is not taught in medical schools, there are no specific postgraduate courses for the management of this pathology and specialists are orphans of specific and regulated training programs that can facilitate and standardize their professional development.
Everything expressed above highlights the importance of the generation of a specific doctrinal body that supports from the best available scientific evidence the actions to be carried out at the care, teaching, research and planning level to respond to what is currently considered as the largest pandemic in human history.Places, Access Requirements and Admission CriteriaNumber of places: 40
General requirementsBe in possession of an official Graduate Degree or have completed at least 180 European credits of the degree.
Be in possession of an official university degree issued in accordance with previous regulations or certify the passing of 180 European credits in said degrees.
Have completed undergraduate degrees according to educational systems outside the European Higher Education Area that certify having completed the equivalent of 180 ECTS credits in said studies.Specific requirements (mandatory requirement to have any of these degrees)Medical specialist in intensive medicine;
Medical specialist in internal medicine;
Physician specialist in anesthesiology and resuscitation;
Physician specialist in pulmonology;
Medical specialist in family and community medicine (with projection towards emergency medicine);
MIR of the aforementioned specialties;
Medical Emergency and / or Hospital or extra-hospital emergencies.Admission CriteriaAverage grade of the file corresponding to the title of medicine. 30 - 40% of the total depending on the rest of the qualifications;
Specialty (giving a greater weight to the specialty of intensive medicine for access). 60% for the specialty of intensive medicine, 50% for the rest;
Accredited level of languages, especially English. 10% of the total.Enrollment
Interested parties must carry out the following steps:Apply for admission through the Unia Portal;
Send the documentation listed below to the address by email:Photocopy of the DNI.
Certified photocopy of the Academic Title that gives access to the Program or proof of having paid the rights to issue it.
Documentation indicated in the section "Places, Access Requirements and Admission Criteria", for the purposes of access and assessment.Once your application and its documentation have been verified, it will be validated and those admitted must formalize the enrollment through the on-line procedure.
The deadline to register is from July 21 to November 2, 2021, inclusive.
Once the student has formalized their enrollment, they must send the proof of having paid it to students.sevilla@unia.esAmount and PaymentPublic prices for administrative services:Tuition: € 930.00 (€ 31.00 / credit).
File opening: € 40.00.
Identity card issuance: € 4.50.Once the 30 ECTS has been passed, students will be able to request:Academic certificate.
Issuance of Title.The payment of the registration fee (€ 974.50) can be made in a single payment, when formalizing the registration; or split it into two installments. The first one, corresponding to 50% of the registration fee and the administrative fees (509.50 euros) at the time of formalizing the registration; the second, corresponding to the other 50% of the amount (465.00 euros), before January 15, 2022.
The registration fee may be paid by cash, direct debit or by transfer to the bank account indicated below, stating the name and surname of the student and the academic activity (0546 - Diploma of Specialization in Emerging Diseases. multidisciplinary patient with severe COVID-19).Academic programThe Diploma has a total of 30 ECTS, which are distributed in the following Modules:
Module 1: Pathophysiology and clinical expression of SARS-CoV-2 infection. The diagnostic process of COVID - 19
(6 ECTS)Subject 1: Pathophysiology and clinical expression (2 ECTS)
Subject 2: Diagnostic Methodology (4 ECTS)Module 2: Involvement by organs, devices and systems in COVID-19
(12 ECTS)Subject 1: Organ dysfunction and chronobiopathology (10 ECTS)
Subject 2: Standardization of gravity (2 ECTS)Module 3: Therapeutic Resources
(12 ECTS)Subject 1: Targeted therapy (6 ECTS)
Subject 2: Organ Support Therapy (6 ECTS)As an end point of the different modules, a simulation based on non-immersive virtual reality techniques will be carried out as an electronic instrument of non-educational application to address one of the fundamental aspects in the control of the patient affected by acute respiratory failure within COVID -19 as they are:Instrumentation of the airway by video laryngoscopy.
High-flow conditioned oxygen therapy.
High-performance mechanical ventilation and monitoring of basic ventilatory mechanics.
